1. Home
  2. TNGX vs AGNCM Comparison

TNGX vs AGNCM Comparison

Compare TNGX & AGNCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

N/A

Current Price

$19.58

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNCM

AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

N/A

Current Price

$24.67

Market Cap

0.0

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
TNGX
AGNCM
Founded
2014
2008
Country
United States
United States
Employees
137
54
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
N/A
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TNGX
AGNCM
Price
$19.58
$24.67
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$18.75
N/A
AVG Volume (30 Days)
3.7M
15.7K
Earning Date
03-05-2026
01-26-2026
Dividend Yield
N/A
9.12%
EPS Growth
26.89
N/A
EPS
N/A
N/A
Revenue
$62,384,000.00
N/A
Revenue This Year
N/A
$13.57
Revenue Next Year
N/A
$60.72
P/E Ratio
N/A
$17.72
Revenue Growth
48.29
N/A
52 Week Low
$1.04
$23.01
52 Week High
$19.81
$25.49

Technical Indicators

Market Signals
Indicator
TNGX
AGNCM
Relative Strength Index (RSI) 76.60 41.96
Support Level $5.98 $24.50
Resistance Level N/A $24.78
Average True Range (ATR) 1.30 0.14
MACD 0.23 -0.03
Stochastic Oscillator 96.36 43.10

Price Performance

Historical Comparison
TNGX
AGNCM

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: